The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
8X8 INC NEW NOTE 0.500% 2/0 282914AB6 6,966 5,000,000 PRN   SOLE   5,000,000 0 0
AKAMAI TECHNOLOGIES INC NOTE 0.125% 5/0 00971TAJ0 43,996 36,240,000 PRN   SOLE   36,240,000 0 0
ALTERYX INC NOTE 0.500% 8/0 02156BAD5 8,027 8,500,000 PRN   SOLE   8,500,000 0 0
APELLIS PHARMACEUTICALS INC NOTE 3.500% 9/1 03753UAB2 7,043 5,000,000 PRN   SOLE   5,000,000 0 0
AT&T INC COM 00206R102 539 17,800 SH   SOLE   17,800 0 0
AVAYA HLDGS CORP NOTE 2.250% 6/1 05351XAB7 45,360 36,500,000 PRN   SOLE   36,500,000 0 0
CYTOKINETICS INC NOTE 4.000%11/1 23282WAA8 15,486 6,500,000 PRN   SOLE   6,500,000 0 0
EVOLENT HEALTH INC NOTE 1.500%10/1 30050BAD3 4,765 5,000,000 PRN   SOLE   5,000,000 0 0
EXACT SCIENCES CORP NOTE 1.000% 1/1 30063PAA3 32,858 17,483,000 PRN   SOLE   17,483,000 0 0
FIREEYE INC NOTE 1.625% 6/0 31816QAD3 34,701 34,833,000 PRN   SOLE   34,833,000 0 0
FLEXION THERAPEUTICS INC NOTE 3.375% 5/0 33938JAB2 10,988 12,158,000 PRN   SOLE   12,158,000 0 0
II-VI INC NOTE 0.250% 9/0 902104AB4 38,013 24,900,000 PRN   SOLE   24,900,000 0 0
INFINERA CORP NOTE 2.500% 3/0 45667GAE3 11,119 7,600,000 PRN   SOLE   7,600,000 0 0
INFINERA CORP COM 45667G103 1,006 104,517 SH   SOLE   104,517 0 0
IONIS PHARMACEUTICALS INC NOTE 0.125%12/1 462222AB6 13,865 14,500,000 PRN   SOLE   14,500,000 0 0
IRONWOOD PHARMACEUTICALS INC NOTE 0.750% 6/1 46333XAF5 5,870 5,300,000 PRN   SOLE   5,300,000 0 0
ITRON INC COM 465741106 355 4,000 SH   SOLE   4,000 0 0
KARYOPHARM THERAPEUTICS INC NOTE 3.000%10/1 48576UAA4 9,367 9,000,000 PRN   SOLE   9,000,000 0 0
LIBERTY MEDIA CORP DEL DEB 2.250% 9/3 531229AE2 22,634 21,808,156 PRN   SOLE   21,808,156 0 0
LUMENTUM HLDGS INC NOTE 0.250% 3/1 55024UAB5 20,910 13,000,000 PRN   SOLE   13,000,000 0 0
NEW RELIC INC NOTE 0.500% 5/0 64829BAB6 62,200 63,328,000 PRN   SOLE   63,328,000 0 0
NUANCE COMMUNICATIONS INC DBCV 1.000%12/1 67020YAK6 101,015 54,544,000 PRN   SOLE   54,544,000 0 0
NUTANIX INC NOTE 1/1 67059NAB4 3,684 3,761,000 PRN   SOLE   3,761,000 0 0
OMEROS CORP NOTE 5.250% 2/1 682143AG7 2,498 2,000,000 PRN   SOLE   2,000,000 0 0
OMEROS CORP NOTE 6.250%11/1 682143AE2 15,874 13,200,000 PRN   SOLE   13,200,000 0 0
OPKO HEALTH INC NOTE 4.500% 2/1 68375NAD5 8,296 6,200,000 PRN   SOLE   6,200,000 0 0
PLURALSIGHT INC NOTE 0.375% 3/0 72941BAB2 13,310 13,500,000 PRN   SOLE   13,500,000 0 0
PTC THERAPEUTICS INC NOTE 3.000% 8/1 69366JAB7 9,796 8,500,000 PRN   SOLE   8,500,000 0 0
RAMBUS INC DEL NOTE 1.375% 2/0 750917AG1 16,184 13,500,000 PRN   SOLE   13,500,000 0 0
REALPAGE INC NOTE 1.500%11/1 75606NAB5 41,728 20,000,000 PRN   SOLE   20,000,000 0 0
RETROPHIN INC NOTE 2.500% 9/1 761299AB2 28,016 27,582,000 PRN   SOLE   27,582,000 0 0
SNAP INC NOTE 0.750% 8/0 83304AAB2 41,329 17,500,000 PRN   SOLE   17,500,000 0 0
SUPERNUS PHARMACEUTICALS INC NOTE 0.625% 4/0 868459AD0 36,345 37,347,000 PRN   SOLE   37,347,000 0 0
TERADYNE INC NOTE 1.250%12/1 880770AG7 89,300 23,202,000 PRN   SOLE   23,202,000 0 0
VONAGE HLDGS CORP NOTE 1.750% 6/0 92886TAJ1 15,811 15,070,000 PRN   SOLE   15,070,000 0 0